M. Liza Lindenberg, M.D.
- Center for Cancer Research
- National Cancer Institute
- Bldg 10, Rm B3B47A
- Bethesda, MD 20892
- 240-760-6109
- liza.lindenberg@nih.gov
RESEARCH SUMMARY
Liza Lindenberg, M.D. is a medical school graduate from the Uniformed Services University of the Health Sciences and was an Army physician for over 14 years prior to transferring to the U.S. Public Health Service and MIB in 2010. She is board certified in Nuclear Medicine and Family Medicine. Her research interests include PET tracers as biomarkers for therapeutic response in cancer treatments.
Areas of Expertise
Information for Patients
Learn more about our clinical trials and the highly specialized care teams that lead them.
M. Liza Lindenberg, M.D.
Clinical Trials
Publications
A pilot study of the value of 18F-fluoro-deoxy-thymidine PET/CT in predicting viable lymphoma in residual 18F-FDG avid masses after completion of therapy
Does focal incidental 18F-FDG PET/CT uptake in the prostate have significance?
PET/CT imaging of renal cell carcinoma with (18)F-VM4-037: a phase II pilot study
Safety and biodistribution of 111In-amatuximab in patients with mesothelin expressing cancers using single photon emission computed tomography-computed tomography (SPECT-CT) imaging.
Prospective Study Evaluating Na18F-Positron Emission Tomography/Computed Tomography (NaF-PET/CT) in Predicting Clinical Outcomes and Survival in Advanced Prostate Cancer
Biography
M. Liza Lindenberg, M.D.
Liza Lindenberg MD is a medical school graduate from the Uniformed Services University of the Health Sciences and was an Army physician for over 14 years prior to transferring to the US Public Health Service and MIP in 2010. She is board certified in Nuclear Medicine and Family Medicine. Her research interests include PET tracers as biomarkers for therapeutic response in cancer treatments.